Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma

Fig. 3

Survival analyses based on PD-L1 expression. Kaplan–Meier survival curves for PFS for all patients (a) and those with second-line treatment (b). Kaplan–Meier survival curves for OS (c). PFS difference in response to the combined expression of PD-L1 and TILs (d). Abbreviation: Programmed death-ligand 1(PD-L1), progression-free survival (PFS), overall survival (OS), tumour infiltrating lymphocytes (TILs). *This figure was generated with GraphPad Prism version 5 (Graph Pad Software Inc., San Diego, CA, USA)

Back to article page
\